Global Polio Vaccine Market Analysis and Forecast 2024-2030
Summary
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.
Polio Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Polio Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polio Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
According to APO Research, The global Polio Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Polio Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Polio Vaccine include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med and Halfkin Bio-Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Polio Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Polio Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Polio Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Polio Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Polio Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Polio Vaccine sales, projected growth trends, production technology, application and end-user industry.
Polio Vaccine segment by Company
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Polio Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Polio Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Polio Vaccine Market by Type
1.2.1 Global Polio Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Market by Application
1.3.1 Global Polio Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 POLIO VACCINE MARKET DYNAMICS
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Polio Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Polio Vaccine Revenue by Region
3.2.1 Global Polio Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Polio Vaccine Revenue by Region (2019-2024)
3.2.3 Global Polio Vaccine Revenue by Region (2025-2030)
3.2.4 Global Polio Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Polio Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Polio Vaccine Sales by Region
3.4.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Polio Vaccine Sales by Region (2019-2024)
3.4.3 Global Polio Vaccine Sales by Region (2025-2030)
3.4.4 Global Polio Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Polio Vaccine Revenue by Manufacturers
4.1.1 Global Polio Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Polio Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Polio Vaccine Sales by Manufacturers
4.2.1 Global Polio Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Polio Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Polio Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Polio Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Polio Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Polio Vaccine Manufacturers, Product Type & Application
4.7 Global Polio Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Polio Vaccine Market CR5 and HHI
4.8.2 2023 Polio Vaccine Tier 1, Tier 2, and Tier
5 POLIO VACCINE MARKET BY TYPE
5.1 Global Polio Vaccine Revenue by Type
5.1.1 Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Polio Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Polio Vaccine Sales by Type
5.2.1 Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Polio Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Polio Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Polio Vaccine Price by Type
6 POLIO VACCINE MARKET BY APPLICATION
6.1 Global Polio Vaccine Revenue by Application
6.1.1 Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Polio Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Polio Vaccine Sales by Application
6.2.1 Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Polio Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Polio Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Polio Vaccine Price by Application
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Comapny Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Polio Vaccine Product Portfolio
7.1.5 Sanofi Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Polio Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 Bibcol
7.3.1 Bibcol Comapny Information
7.3.2 Bibcol Business Overview
7.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Bibcol Polio Vaccine Product Portfolio
7.3.5 Bibcol Recent Developments
7.4 Serum Institute
7.4.1 Serum Institute Comapny Information
7.4.2 Serum Institute Business Overview
7.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Serum Institute Polio Vaccine Product Portfolio
7.4.5 Serum Institute Recent Developments
7.5 Tiantan Biological
7.5.1 Tiantan Biological Comapny Information
7.5.2 Tiantan Biological Business Overview
7.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Tiantan Biological Polio Vaccine Product Portfolio
7.5.5 Tiantan Biological Recent Developments
7.6 IMBCA
7.6.1 IMBCA Comapny Information
7.6.2 IMBCA Business Overview
7.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 IMBCA Polio Vaccine Product Portfolio
7.6.5 IMBCA Recent Developments
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Comapny Information
7.7.2 Panacea Biotec Ltd Business Overview
7.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
7.7.5 Panacea Biotec Ltd Recent Developments
7.8 Bio-Med
7.8.1 Bio-Med Comapny Information
7.8.2 Bio-Med Business Overview
7.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Bio-Med Polio Vaccine Product Portfolio
7.8.5 Bio-Med Recent Developments
7.9 Halfkin Bio-Pharmaceuticals
7.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
7.9.2 Halfkin Bio-Pharmaceuticals Business Overview
7.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
7.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
8 NORTH AMERICA
8.1 North America Polio Vaccine Market Size by Type
8.1.1 North America Polio Vaccine Revenue by Type (2019-2030)
8.1.2 North America Polio Vaccine Sales by Type (2019-2030)
8.1.3 North America Polio Vaccine Price by Type (2019-2030)
8.2 North America Polio Vaccine Market Size by Application
8.2.1 North America Polio Vaccine Revenue by Application (2019-2030)
8.2.2 North America Polio Vaccine Sales by Application (2019-2030)
8.2.3 North America Polio Vaccine Price by Application (2019-2030)
8.3 North America Polio Vaccine Market Size by Country
8.3.1 North America Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Polio Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Polio Vaccine Market Size by Type
9.1.1 Europe Polio Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Polio Vaccine Sales by Type (2019-2030)
9.1.3 Europe Polio Vaccine Price by Type (2019-2030)
9.2 Europe Polio Vaccine Market Size by Application
9.2.1 Europe Polio Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Polio Vaccine Sales by Application (2019-2030)
9.2.3 Europe Polio Vaccine Price by Application (2019-2030)
9.3 Europe Polio Vaccine Market Size by Country
9.3.1 Europe Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Polio Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Polio Vaccine Market Size by Type
10.1.1 China Polio Vaccine Revenue by Type (2019-2030)
10.1.2 China Polio Vaccine Sales by Type (2019-2030)
10.1.3 China Polio Vaccine Price by Type (2019-2030)
10.2 China Polio Vaccine Market Size by Application
10.2.1 China Polio Vaccine Revenue by Application (2019-2030)
10.2.2 China Polio Vaccine Sales by Application (2019-2030)
10.2.3 China Polio Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Polio Vaccine Market Size by Type
11.1.1 Asia Polio Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Polio Vaccine Sales by Type (2019-2030)
11.1.3 Asia Polio Vaccine Price by Type (2019-2030)
11.2 Asia Polio Vaccine Market Size by Application
11.2.1 Asia Polio Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Polio Vaccine Sales by Application (2019-2030)
11.2.3 Asia Polio Vaccine Price by Application (2019-2030)
11.3 Asia Polio Vaccine Market Size by Country
11.3.1 Asia Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Polio Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Polio Vaccine Market Size by Type
12.1.1 MEALA Polio Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Polio Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Polio Vaccine Price by Type (2019-2030)
12.2 MEALA Polio Vaccine Market Size by Application
12.2.1 MEALA Polio Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Polio Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Polio Vaccine Price by Application (2019-2030)
12.3 MEALA Polio Vaccine Market Size by Country
12.3.1 MEALA Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Polio Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Polio Vaccine Value Chain Analysis
13.1.1 Polio Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Polio Vaccine Production Mode & Process
13.2 Polio Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Polio Vaccine Distributors
13.2.3 Polio Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Polio Vaccine Market by Type
1.2.1 Global Polio Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Polio Vaccine Market by Application
1.3.1 Global Polio Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 POLIO VACCINE MARKET DYNAMICS
2.1 Polio Vaccine Industry Trends
2.2 Polio Vaccine Industry Drivers
2.3 Polio Vaccine Industry Opportunities and Challenges
2.4 Polio Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Polio Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Polio Vaccine Revenue by Region
3.2.1 Global Polio Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Polio Vaccine Revenue by Region (2019-2024)
3.2.3 Global Polio Vaccine Revenue by Region (2025-2030)
3.2.4 Global Polio Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Polio Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Polio Vaccine Sales by Region
3.4.1 Global Polio Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Polio Vaccine Sales by Region (2019-2024)
3.4.3 Global Polio Vaccine Sales by Region (2025-2030)
3.4.4 Global Polio Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Polio Vaccine Revenue by Manufacturers
4.1.1 Global Polio Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Polio Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Polio Vaccine Sales by Manufacturers
4.2.1 Global Polio Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Polio Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Polio Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Polio Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Polio Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Polio Vaccine Manufacturers, Product Type & Application
4.7 Global Polio Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Polio Vaccine Market CR5 and HHI
4.8.2 2023 Polio Vaccine Tier 1, Tier 2, and Tier
5 POLIO VACCINE MARKET BY TYPE
5.1 Global Polio Vaccine Revenue by Type
5.1.1 Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Polio Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Polio Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Polio Vaccine Sales by Type
5.2.1 Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Polio Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Polio Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Polio Vaccine Price by Type
6 POLIO VACCINE MARKET BY APPLICATION
6.1 Global Polio Vaccine Revenue by Application
6.1.1 Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Polio Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Polio Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Polio Vaccine Sales by Application
6.2.1 Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Polio Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Polio Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Polio Vaccine Price by Application
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Comapny Information
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Polio Vaccine Product Portfolio
7.1.5 Sanofi Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Polio Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 Bibcol
7.3.1 Bibcol Comapny Information
7.3.2 Bibcol Business Overview
7.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Bibcol Polio Vaccine Product Portfolio
7.3.5 Bibcol Recent Developments
7.4 Serum Institute
7.4.1 Serum Institute Comapny Information
7.4.2 Serum Institute Business Overview
7.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Serum Institute Polio Vaccine Product Portfolio
7.4.5 Serum Institute Recent Developments
7.5 Tiantan Biological
7.5.1 Tiantan Biological Comapny Information
7.5.2 Tiantan Biological Business Overview
7.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Tiantan Biological Polio Vaccine Product Portfolio
7.5.5 Tiantan Biological Recent Developments
7.6 IMBCA
7.6.1 IMBCA Comapny Information
7.6.2 IMBCA Business Overview
7.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 IMBCA Polio Vaccine Product Portfolio
7.6.5 IMBCA Recent Developments
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Comapny Information
7.7.2 Panacea Biotec Ltd Business Overview
7.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
7.7.5 Panacea Biotec Ltd Recent Developments
7.8 Bio-Med
7.8.1 Bio-Med Comapny Information
7.8.2 Bio-Med Business Overview
7.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Bio-Med Polio Vaccine Product Portfolio
7.8.5 Bio-Med Recent Developments
7.9 Halfkin Bio-Pharmaceuticals
7.9.1 Halfkin Bio-Pharmaceuticals Comapny Information
7.9.2 Halfkin Bio-Pharmaceuticals Business Overview
7.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
7.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
8 NORTH AMERICA
8.1 North America Polio Vaccine Market Size by Type
8.1.1 North America Polio Vaccine Revenue by Type (2019-2030)
8.1.2 North America Polio Vaccine Sales by Type (2019-2030)
8.1.3 North America Polio Vaccine Price by Type (2019-2030)
8.2 North America Polio Vaccine Market Size by Application
8.2.1 North America Polio Vaccine Revenue by Application (2019-2030)
8.2.2 North America Polio Vaccine Sales by Application (2019-2030)
8.2.3 North America Polio Vaccine Price by Application (2019-2030)
8.3 North America Polio Vaccine Market Size by Country
8.3.1 North America Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Polio Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Polio Vaccine Market Size by Type
9.1.1 Europe Polio Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Polio Vaccine Sales by Type (2019-2030)
9.1.3 Europe Polio Vaccine Price by Type (2019-2030)
9.2 Europe Polio Vaccine Market Size by Application
9.2.1 Europe Polio Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Polio Vaccine Sales by Application (2019-2030)
9.2.3 Europe Polio Vaccine Price by Application (2019-2030)
9.3 Europe Polio Vaccine Market Size by Country
9.3.1 Europe Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Polio Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Polio Vaccine Market Size by Type
10.1.1 China Polio Vaccine Revenue by Type (2019-2030)
10.1.2 China Polio Vaccine Sales by Type (2019-2030)
10.1.3 China Polio Vaccine Price by Type (2019-2030)
10.2 China Polio Vaccine Market Size by Application
10.2.1 China Polio Vaccine Revenue by Application (2019-2030)
10.2.2 China Polio Vaccine Sales by Application (2019-2030)
10.2.3 China Polio Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Polio Vaccine Market Size by Type
11.1.1 Asia Polio Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Polio Vaccine Sales by Type (2019-2030)
11.1.3 Asia Polio Vaccine Price by Type (2019-2030)
11.2 Asia Polio Vaccine Market Size by Application
11.2.1 Asia Polio Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Polio Vaccine Sales by Application (2019-2030)
11.2.3 Asia Polio Vaccine Price by Application (2019-2030)
11.3 Asia Polio Vaccine Market Size by Country
11.3.1 Asia Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Polio Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Polio Vaccine Market Size by Type
12.1.1 MEALA Polio Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Polio Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Polio Vaccine Price by Type (2019-2030)
12.2 MEALA Polio Vaccine Market Size by Application
12.2.1 MEALA Polio Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Polio Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Polio Vaccine Price by Application (2019-2030)
12.3 MEALA Polio Vaccine Market Size by Country
12.3.1 MEALA Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Polio Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Polio Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Polio Vaccine Value Chain Analysis
13.1.1 Polio Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Polio Vaccine Production Mode & Process
13.2 Polio Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Polio Vaccine Distributors
13.2.3 Polio Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Polio Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Inactivated Polio Vaccine (IPV) Major Manufacturers
Table 3. Oral Polio Vaccine (OPV) Major Manufacturers
Table 4. Global Polio Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Public Major Manufacturers
Table 6. Private Major Manufacturers
Table 7. Polio Vaccine Industry Trends
Table 8. Polio Vaccine Industry Drivers
Table 9. Polio Vaccine Industry Opportunities and Challenges
Table 10. Polio Vaccine Industry Restraints
Table 11. Global Polio Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Polio Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Polio Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Polio Vaccine Revenue Market Share by Region (2019-2024)
Table 15. Global Polio Vaccine Revenue Market Share by Region (2025-2030)
Table 16. Global Polio Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 17. Global Polio Vaccine Sales by Region (2019-2024) & (M Doses)
Table 18. Global Polio Vaccine Sales by Region (2025-2030) & (M Doses)
Table 19. Global Polio Vaccine Sales Market Share by Region (2019-2024)
Table 20. Global Polio Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Polio Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Polio Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Polio Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Polio Vaccine Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 26. Global Polio Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Polio Vaccine Manufacturers, Product Type & Application
Table 29. Global Polio Vaccine Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Polio Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Polio Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Polio Vaccine Revenue Market Share by Type (2019-2024)
Table 36. Global Polio Vaccine Revenue Market Share by Type (2025-2030)
Table 37. Global Polio Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 38. Global Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 39. Global Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 40. Global Polio Vaccine Sales Market Share by Type (2019-2024)
Table 41. Global Polio Vaccine Sales Market Share by Type (2025-2030)
Table 42. Global Polio Vaccine Price by Type (2019-2024) & (USD/K Doses)
Table 43. Global Polio Vaccine Price by Type (2025-2030) & (USD/K Doses)
Table 44. Global Polio Vaccine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Polio Vaccine Revenue Market Share by Application (2019-2024)
Table 48. Global Polio Vaccine Revenue Market Share by Application (2025-2030)
Table 49. Global Polio Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 50. Global Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 51. Global Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 52. Global Polio Vaccine Sales Market Share by Application (2019-2024)
Table 53. Global Polio Vaccine Sales Market Share by Application (2025-2030)
Table 54. Global Polio Vaccine Price by Application (2019-2024) & (USD/K Doses)
Table 55. Global Polio Vaccine Price by Application (2025-2030) & (USD/K Doses)
Table 56. Sanofi Company Information
Table 57. Sanofi Business Overview
Table 58. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 59. Sanofi Polio Vaccine Product Portfolio
Table 60. Sanofi Recent Development
Table 61. GSK Company Information
Table 62. GSK Business Overview
Table 63. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 64. GSK Polio Vaccine Product Portfolio
Table 65. GSK Recent Development
Table 66. Bibcol Company Information
Table 67. Bibcol Business Overview
Table 68. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 69. Bibcol Polio Vaccine Product Portfolio
Table 70. Bibcol Recent Development
Table 71. Serum Institute Company Information
Table 72. Serum Institute Business Overview
Table 73. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 74. Serum Institute Polio Vaccine Product Portfolio
Table 75. Serum Institute Recent Development
Table 76. Tiantan Biological Company Information
Table 77. Tiantan Biological Business Overview
Table 78. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 79. Tiantan Biological Polio Vaccine Product Portfolio
Table 80. Tiantan Biological Recent Development
Table 81. IMBCA Company Information
Table 82. IMBCA Business Overview
Table 83. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 84. IMBCA Polio Vaccine Product Portfolio
Table 85. IMBCA Recent Development
Table 86. Panacea Biotec Ltd Company Information
Table 87. Panacea Biotec Ltd Business Overview
Table 88. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 89. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 90. Panacea Biotec Ltd Recent Development
Table 91. Bio-Med Company Information
Table 92. Bio-Med Business Overview
Table 93. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 94. Bio-Med Polio Vaccine Product Portfolio
Table 95. Bio-Med Recent Development
Table 96. Halfkin Bio-Pharmaceuticals Company Information
Table 97. Halfkin Bio-Pharmaceuticals Business Overview
Table 98. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 99. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 100. Halfkin Bio-Pharmaceuticals Recent Development
Table 101. North America Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 102. North America Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 103. North America Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 104. North America Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 105. North America Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 106. North America Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 107. North America Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 108. North America Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 109. North America Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 110. North America Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 111. North America Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 112. North America Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 113. North America Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. North America Polio Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 115. North America Polio Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 116. North America Polio Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 117. North America Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 118. North America Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 119. North America Polio Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 120. North America Polio Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 121. US Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 122. Canada Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 123. Europe Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 124. Europe Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 125. Europe Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 126. Europe Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 127. Europe Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 128. Europe Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 129. Europe Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 130. Europe Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 131. Europe Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 132. Europe Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 133. Europe Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 134. Europe Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 135. Europe Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 136. Europe Polio Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 137. Europe Polio Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 138. Europe Polio Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 139. Europe Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 140. Europe Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 141. Europe Polio Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 142. Europe Polio Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 143. Germany Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 144. France Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 145. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 146. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 147. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 148. China Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 149. China Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 150. China Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 151. China Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 152. China Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 153. China Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 154. China Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 155. China Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 156. China Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 157. China Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 158. China Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 159. China Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 160. Asia Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 161. Asia Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 162. Asia Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 163. Asia Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 164. Asia Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 165. Asia Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 166. Asia Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 167. Asia Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 168. Asia Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 169. Asia Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 170. Asia Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 171. Asia Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 172. Asia Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 173. Asia Polio Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 174. Asia Polio Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 175. Asia Polio Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 176. Asia Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 177. Asia Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 178. Asia Polio Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 179. Asia Polio Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 180. Japan Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 181. South Korea Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 182. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 183. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 184. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 185. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 186. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 187. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 188. MEALA Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 189. MEALA Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 190. MEALA Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 191. MEALA Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 192. MEALA Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 193. MEALA Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 194. MEALA Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 195. MEALA Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 196. MEALA Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 197. MEALA Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 198. MEALA Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 199. MEALA Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 200. MEALA Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 201. MEALA Polio Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 202. MEALA Polio Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 203. MEALA Polio Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 204. MEALA Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 205. MEALA Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 206. MEALA Polio Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 207. MEALA Polio Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 208. Mexico Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 209. Brazil Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 210. Israel Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 211. Argentina Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 212. Colombia Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 213. Turkey Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 214. Saudi Arabia Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 215. UAE Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 216. Key Raw Materials
Table 217. Raw Materials Key Suppliers
Table 218. Polio Vaccine Distributors List
Table 219. Polio Vaccine Customers List
Table 220. Research Programs/Design for This Report
Table 221. Authors List of This Report
Table 222. Secondary Sources
Table 223. Primary Sources
Table 1. Global Polio Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Inactivated Polio Vaccine (IPV) Major Manufacturers
Table 3. Oral Polio Vaccine (OPV) Major Manufacturers
Table 4. Global Polio Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Public Major Manufacturers
Table 6. Private Major Manufacturers
Table 7. Polio Vaccine Industry Trends
Table 8. Polio Vaccine Industry Drivers
Table 9. Polio Vaccine Industry Opportunities and Challenges
Table 10. Polio Vaccine Industry Restraints
Table 11. Global Polio Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Polio Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Polio Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Polio Vaccine Revenue Market Share by Region (2019-2024)
Table 15. Global Polio Vaccine Revenue Market Share by Region (2025-2030)
Table 16. Global Polio Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 17. Global Polio Vaccine Sales by Region (2019-2024) & (M Doses)
Table 18. Global Polio Vaccine Sales by Region (2025-2030) & (M Doses)
Table 19. Global Polio Vaccine Sales Market Share by Region (2019-2024)
Table 20. Global Polio Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Polio Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Polio Vaccine Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Polio Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Polio Vaccine Sales Price (USD/K Doses) of Manufacturers (2019-2024)
Table 26. Global Polio Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Polio Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Polio Vaccine Manufacturers, Product Type & Application
Table 29. Global Polio Vaccine Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Polio Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Polio Vaccine Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Polio Vaccine Revenue Market Share by Type (2019-2024)
Table 36. Global Polio Vaccine Revenue Market Share by Type (2025-2030)
Table 37. Global Polio Vaccine Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 38. Global Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 39. Global Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 40. Global Polio Vaccine Sales Market Share by Type (2019-2024)
Table 41. Global Polio Vaccine Sales Market Share by Type (2025-2030)
Table 42. Global Polio Vaccine Price by Type (2019-2024) & (USD/K Doses)
Table 43. Global Polio Vaccine Price by Type (2025-2030) & (USD/K Doses)
Table 44. Global Polio Vaccine Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Polio Vaccine Revenue Market Share by Application (2019-2024)
Table 48. Global Polio Vaccine Revenue Market Share by Application (2025-2030)
Table 49. Global Polio Vaccine Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 50. Global Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 51. Global Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 52. Global Polio Vaccine Sales Market Share by Application (2019-2024)
Table 53. Global Polio Vaccine Sales Market Share by Application (2025-2030)
Table 54. Global Polio Vaccine Price by Application (2019-2024) & (USD/K Doses)
Table 55. Global Polio Vaccine Price by Application (2025-2030) & (USD/K Doses)
Table 56. Sanofi Company Information
Table 57. Sanofi Business Overview
Table 58. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 59. Sanofi Polio Vaccine Product Portfolio
Table 60. Sanofi Recent Development
Table 61. GSK Company Information
Table 62. GSK Business Overview
Table 63. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 64. GSK Polio Vaccine Product Portfolio
Table 65. GSK Recent Development
Table 66. Bibcol Company Information
Table 67. Bibcol Business Overview
Table 68. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 69. Bibcol Polio Vaccine Product Portfolio
Table 70. Bibcol Recent Development
Table 71. Serum Institute Company Information
Table 72. Serum Institute Business Overview
Table 73. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 74. Serum Institute Polio Vaccine Product Portfolio
Table 75. Serum Institute Recent Development
Table 76. Tiantan Biological Company Information
Table 77. Tiantan Biological Business Overview
Table 78. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 79. Tiantan Biological Polio Vaccine Product Portfolio
Table 80. Tiantan Biological Recent Development
Table 81. IMBCA Company Information
Table 82. IMBCA Business Overview
Table 83. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 84. IMBCA Polio Vaccine Product Portfolio
Table 85. IMBCA Recent Development
Table 86. Panacea Biotec Ltd Company Information
Table 87. Panacea Biotec Ltd Business Overview
Table 88. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 89. Panacea Biotec Ltd Polio Vaccine Product Portfolio
Table 90. Panacea Biotec Ltd Recent Development
Table 91. Bio-Med Company Information
Table 92. Bio-Med Business Overview
Table 93. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 94. Bio-Med Polio Vaccine Product Portfolio
Table 95. Bio-Med Recent Development
Table 96. Halfkin Bio-Pharmaceuticals Company Information
Table 97. Halfkin Bio-Pharmaceuticals Business Overview
Table 98. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 99. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
Table 100. Halfkin Bio-Pharmaceuticals Recent Development
Table 101. North America Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 102. North America Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 103. North America Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 104. North America Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 105. North America Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 106. North America Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 107. North America Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 108. North America Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 109. North America Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 110. North America Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 111. North America Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 112. North America Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 113. North America Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. North America Polio Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 115. North America Polio Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 116. North America Polio Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 117. North America Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 118. North America Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 119. North America Polio Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 120. North America Polio Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 121. US Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 122. Canada Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 123. Europe Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 124. Europe Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 125. Europe Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 126. Europe Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 127. Europe Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 128. Europe Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 129. Europe Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 130. Europe Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 131. Europe Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 132. Europe Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 133. Europe Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 134. Europe Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 135. Europe Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 136. Europe Polio Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 137. Europe Polio Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 138. Europe Polio Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 139. Europe Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 140. Europe Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 141. Europe Polio Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 142. Europe Polio Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 143. Germany Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 144. France Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 145. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 146. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 147. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 148. China Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 149. China Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 150. China Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 151. China Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 152. China Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 153. China Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 154. China Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 155. China Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 156. China Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 157. China Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 158. China Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 159. China Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 160. Asia Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 161. Asia Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 162. Asia Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 163. Asia Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 164. Asia Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 165. Asia Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 166. Asia Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 167. Asia Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 168. Asia Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 169. Asia Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 170. Asia Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 171. Asia Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 172. Asia Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 173. Asia Polio Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 174. Asia Polio Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 175. Asia Polio Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 176. Asia Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 177. Asia Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 178. Asia Polio Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 179. Asia Polio Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 180. Japan Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 181. South Korea Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 182. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 183. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 184. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 185. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 186. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 187. Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 188. MEALA Polio Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 189. MEALA Polio Vaccine Revenue by Type (2025-2030) & (US$ Million)
Table 190. MEALA Polio Vaccine Sales by Type (2019-2024) & (M Doses)
Table 191. MEALA Polio Vaccine Sales by Type (2025-2030) & (M Doses)
Table 192. MEALA Polio Vaccine Sales Price by Type (2019-2024) & (USD/K Doses)
Table 193. MEALA Polio Vaccine Sales Price by Type (2025-2030) & (USD/K Doses)
Table 194. MEALA Polio Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 195. MEALA Polio Vaccine Revenue by Application (2025-2030) & (US$ Million)
Table 196. MEALA Polio Vaccine Sales by Application (2019-2024) & (M Doses)
Table 197. MEALA Polio Vaccine Sales by Application (2025-2030) & (M Doses)
Table 198. MEALA Polio Vaccine Sales Price by Application (2019-2024) & (USD/K Doses)
Table 199. MEALA Polio Vaccine Sales Price by Application (2025-2030) & (USD/K Doses)
Table 200. MEALA Polio Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 201. MEALA Polio Vaccine Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 202. MEALA Polio Vaccine Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 203. MEALA Polio Vaccine Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 204. MEALA Polio Vaccine Sales by Country (2019-2024) & (M Doses)
Table 205. MEALA Polio Vaccine Sales by Country (2025-2030) & (M Doses)
Table 206. MEALA Polio Vaccine Sales Price by Country (2019-2024) & (USD/K Doses)
Table 207. MEALA Polio Vaccine Sales Price by Country (2025-2030) & (USD/K Doses)
Table 208. Mexico Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 209. Brazil Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 210. Israel Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 211. Argentina Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 212. Colombia Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 213. Turkey Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 214. Saudi Arabia Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 215. UAE Polio Vaccine Revenue (2019-2030) & (US$ Million)
Table 216. Key Raw Materials
Table 217. Raw Materials Key Suppliers
Table 218. Polio Vaccine Distributors List
Table 219. Polio Vaccine Customers List
Table 220. Research Programs/Design for This Report
Table 221. Authors List of This Report
Table 222. Secondary Sources
Table 223. Primary Sources
LIST OF FIGURES
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Polio Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 4. Inactivated Polio Vaccine (IPV) Picture
Figure 5. Oral Polio Vaccine (OPV) Picture
Figure 6. Global Polio Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Polio Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 8. Public Picture
Figure 9. Private Picture
Figure 10. Global Polio Vaccine Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 12. Global Polio Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Polio Vaccine Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Polio Vaccine Revenue Market Share by Region (2019-2030)
Figure 15. Global Polio Vaccine Sales (2019-2030) & (M Doses)
Figure 16. Global Polio Vaccine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 17. Global Polio Vaccine Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 19. Europe Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 20. China Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 21. Asia (Excluding China) Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 22. Middle East, Africa and Latin America (Excluding China) Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 23. Global Polio Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Polio Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Polio Vaccine Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Polio Vaccine Revenue Market Share by Type (2019-2030)
Figure 29. Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 30. Global Polio Vaccine Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Polio Vaccine Sales Market Share by Type (2019-2030)
Figure 32. Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global Polio Vaccine Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global Polio Vaccine Revenue Market Share by Application (2019-2030)
Figure 35. Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 36. Global Polio Vaccine Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Polio Vaccine Sales Market Share by Application (2019-2030)
Figure 38. North America Polio Vaccine Revenue Share by Type (2019-2030)
Figure 39. North America Polio Vaccine Sales Share by Type (2019-2030)
Figure 40. North America Polio Vaccine Revenue Share by Application (2019-2030)
Figure 41. North America Polio Vaccine Sales Share by Application (2019-2030)
Figure 42. North America Polio Vaccine Revenue Share by Country (2019-2030)
Figure 43. North America Polio Vaccine Sales Share by Country (2019-2030)
Figure 44. Europe Polio Vaccine Revenue Share by Type (2019-2030)
Figure 45. Europe Polio Vaccine Sales Share by Type (2019-2030)
Figure 46. Europe Polio Vaccine Revenue Share by Application (2019-2030)
Figure 47. Euro
Figure 1. Polio Vaccine Product Picture
Figure 2. Global Polio Vaccine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Polio Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 4. Inactivated Polio Vaccine (IPV) Picture
Figure 5. Oral Polio Vaccine (OPV) Picture
Figure 6. Global Polio Vaccine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Polio Vaccine Market Size Share 2019 VS 2023 VS 2030
Figure 8. Public Picture
Figure 9. Private Picture
Figure 10. Global Polio Vaccine Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Polio Vaccine Revenue (2019-2030) & (US$ Million)
Figure 12. Global Polio Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Polio Vaccine Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Polio Vaccine Revenue Market Share by Region (2019-2030)
Figure 15. Global Polio Vaccine Sales (2019-2030) & (M Doses)
Figure 16. Global Polio Vaccine Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 17. Global Polio Vaccine Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 19. Europe Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 20. China Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 21. Asia (Excluding China) Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 22. Middle East, Africa and Latin America (Excluding China) Polio Vaccine Sales YoY (2019-2030) & (M Doses)
Figure 23. Global Polio Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Polio Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Polio Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Polio Vaccine Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Polio Vaccine Revenue Market Share by Type (2019-2030)
Figure 29. Global Polio Vaccine Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 30. Global Polio Vaccine Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Polio Vaccine Sales Market Share by Type (2019-2030)
Figure 32. Global Polio Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global Polio Vaccine Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global Polio Vaccine Revenue Market Share by Application (2019-2030)
Figure 35. Global Polio Vaccine Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 36. Global Polio Vaccine Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Polio Vaccine Sales Market Share by Application (2019-2030)
Figure 38. North America Polio Vaccine Revenue Share by Type (2019-2030)
Figure 39. North America Polio Vaccine Sales Share by Type (2019-2030)
Figure 40. North America Polio Vaccine Revenue Share by Application (2019-2030)
Figure 41. North America Polio Vaccine Sales Share by Application (2019-2030)
Figure 42. North America Polio Vaccine Revenue Share by Country (2019-2030)
Figure 43. North America Polio Vaccine Sales Share by Country (2019-2030)
Figure 44. Europe Polio Vaccine Revenue Share by Type (2019-2030)
Figure 45. Europe Polio Vaccine Sales Share by Type (2019-2030)
Figure 46. Europe Polio Vaccine Revenue Share by Application (2019-2030)
Figure 47. Euro
